422 related articles for article (PubMed ID: 8967093)
1. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
Ausch C; Rosen HR; Schiessel R
Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
3. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
Rosen H
Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
[TBL] [Abstract][Full Text] [Related]
4. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemotherapy in gastric carcinoma].
D'Ugo D; Persiani R; Pende V; Picciocchi A
Ann Ital Chir; 2001; 72(1):47-53. PubMed ID: 11464495
[TBL] [Abstract][Full Text] [Related]
6. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
Yu W
Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
[TBL] [Abstract][Full Text] [Related]
7. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
Schuhmacher CP; Fink U; Becker K; Busch R; Dittler HJ; Mueller J; Siewert JR
Cancer; 2001 Mar; 91(5):918-27. PubMed ID: 11251943
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot study.
Orditura M; De Vita F; Muto P; Vitiello F; Murino P; Lieto E; Vecchione L; Romano A; Martinelli E; Renda A; Ferraraccio F; Del Genio A; Ciardiello F; Galizia G
Arch Surg; 2010 Mar; 145(3):233-8. PubMed ID: 20231623
[TBL] [Abstract][Full Text] [Related]
10. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
[TBL] [Abstract][Full Text] [Related]
11. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
12. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
13. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
[TBL] [Abstract][Full Text] [Related]
14. [Systemic neoadjuvant chemotherapy in locally advanced gastric carcinoma: phase II study with 5-fluorouracil, epirubicin and etoposide].
Catania G; Puleo C; Catalano F; Altadonna V; Scilletta S; Migliore M; Iuppa A; Cardì F
Chir Ital; 2000; 52(4):385-91. PubMed ID: 11190529
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.
Alexander HR; Grem JL; Hamilton JM; Pass HI; Hong M; Fraker DL; Steinberg SM; McAtee N; Allegra BC; Johnston PG
Cancer J Sci Am; 1995; 1(1):49-54. PubMed ID: 9166454
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative (neoadjuvant) chemotherapy in multimodality treatment concept of stomach carcinoma].
Meyer HJ; Jähne J; Wilke H; Pichlmayr R
Zentralbl Chir; 1995; 120(2):128-34. PubMed ID: 7709664
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of gastric cancer: a review.
Kelsen D
Isr J Med Sci; 1988; 24(9-10):557-61. PubMed ID: 3060446
[TBL] [Abstract][Full Text] [Related]
19. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
Lygidakis NJ; Sgourakis G; Aphinives P
Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
[TBL] [Abstract][Full Text] [Related]
20. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]